Korean heart rhythm patients tested for safer blood thinner dosing
NCT ID NCT06874894
Summary
This study aims to find the safest and most effective dose of blood thinners for Korean patients with atrial fibrillation, a heart rhythm condition that increases stroke risk. Researchers are enrolling over 1,000 Korean adults who need blood thinners to prevent strokes. The study will track how well the medications prevent blood clots while monitoring for bleeding complications, which may occur more frequently in Asian populations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBRILLATION, ATRIAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chung-Ang University Gwangmyeong Hospital
Gwangmyeong, South Korea
-
Chung-Ang University Hospital
Seoul, 06973, South Korea
Conditions
Explore the condition pages connected to this study.